Skip to content

RESIDENT: Ketamine Prescribing Trends in Alberta Between January 2021 – June 2024 (U of A) | Leslie Truong

2025 APA Scientific Conference

Please click "Next" if you did not attend this session
550%
The session met the stated learning objectives:(Required.)
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
Review the growing evidence for use of ketamine in treatment resistant depression;
Discuss the abuse liability of ketamine;
Analyze trends in ketamine prescribing in Alberta between January 1, 2021, to June 30, 2024; and
Consider future directions for research in the abuse liability of ketamine.
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):(Required.)
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session was educationally relevant.
The presenter was educationally effective.
The session provided interactive opportunities.
The session provided opportunities to identify and/or reflect on what was learned and its potential impact on my practice
Please rate the following on a scale of 1 to 5
(1 - strongly disagree and 5 - strongly agree):(Required.)
Strongly disagree
Disagree
Somewhat disagree
Neither agree or disagree
Somewhat agree
Agree
Strongly agree
The session and presenter did NOT have commercial or other inappropriate bias.
Please provide any other comments you would like to share: